Posts by: Margarida Azevedo, MSc

Margarida Azevedo, MSc

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

November 27, 2017November 27, 2017

Progenity Gets $125M in Financing to Speed Development of IBD Diagnostics, Therapeutics Platform

News

Progenity recently closed a $125 million financing round to accelerate development of its gastrointestinal (GI) platform for inflammatory bowel disease (IBD), including precision molecular diagnostic tools, precision therapeutics, microbiome analytics and ... Read more

November 22, 2017

Takeda, Portal Instruments Partner in Developing Needle-free Drug Delivery Service

News

Takeda Pharmaceutical and Portal Instruments will collaborate to develop and commercialize Portal’s needle-free drug delivery service for potential use with Takeda’s investigational and approved therapies, including treatments for ulcerative colitis ... Read more

November 20, 2017

Eli and Edythe Broad Foundation Awards $1.2 Million to Four UCLA Researchers in IBD

News

Four UCLA researchers conducting early-stage research into inflammatory bowel disease have received four three-year grants totaling $1.2 million from the Eli and Edythe Broad Foundation. The grants bring to more than ... Read more

November 16, 2017November 16, 2017

EU Approves Humira Biosimilar Cyltezo for Treatment of Chronic Inflammatory Diseases

News

The European Commission recently approved Cyltezo, a biosimilar to Humira (adalimumab), for the treatment of chronic inflammatory diseases in adults and children including inflammatory bowel diseases (IBDs) such as Crohn’s disease ... Read more

November 13, 2017November 13, 2017

Start-Up NIMo Wins SPARK Co-Lab 2017 Design Course Pitch Night

News

Medical device start-up NIMo has taken first place at the SPARK Co-Lab 2017 Design Course Pitch Night in Australia, for its wearable technology to self-manage chronic disease such as inflammatory bowel disease ... Read more

November 3, 2017November 3, 2017

Role of Genetics in IBD Development and Treatment Response Focus of Irish Study

News

Genomics Medicine Ireland (GMI) is launching a study to investigate the role genes may play in developing and treating inflammatory bowel disease (IBD), and how genetic risks might be affected by ... Read more

November 2, 2017November 2, 2017

Crohn’s & Colitis Foundation Receives $5 Million Donation to Fund IBD Research

News

The Crohn’s & Colitis Foundation has received $5 million from the Litwin family to fund research on inflammatory bowel disease (IBD). The grant, funded through Litwin IBD Pioneers, will finance studies on ... Read more

October 10, 2017October 10, 2017

TiGenix Presents Positive Results of Potential Crohn’s Therapy, Announces Phase 3 Study

News

TiGenix will present positive results of Cx601 to treat complex perianal fistulas in Crohn’s disease patients at the upcoming World Congress of Gastroenterology ACG 2017 meeting in Orlando, Florida. The company will discuss ... Read more

September 25, 2017

France Is First EU Country to Give Abivax Go-ahead to Test ABX464 in Ulcerative Colitis

News

France has become the first European country to give Abivax a green light to start clinical trials of ABX464 as a treatment for moderate-to-severe active ulcerative colitis. The therapy candidate is already being tested ... Read more

September 22, 2017

Oxford University Press to Publish Crohn’s & Colitis Foundation’s Inflammatory Bowel Diseases Journal

News

Oxford University Press will begin publishing the Crohn’s & Colitis Foundation’s Inflammatory Bowel Diseases journal in 2018. While Inflammatory Bowel Diseases has been around for more than 20 years, the partnership ... Read more